This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Plantar fibromatosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Plantar fibromatosis or Ledderhose's disease (named after George Ledderhose who first described it in 1894) is a benign condition of unknown aetiology

  • been associated with alcohol dependence, diabetic mellitus, liver dysfunction, use of anticonvulsants, and genetic factors
  • also associated with Dupuytren's contracture and penile fibromatosis or Peyronie's disease
  • characterized by localized aggressive proliferation of the connective tissue which produces collagen fibers, leading to the formation of lump or nodules over the sole of the foot
    • nodule is usually slow growing and does not metastasize
    • similar pattern of disease is noted in Dupuytren's disease (DD) of the hand in which the palmar aponeurosis is affected
      • smilarity of the disease has led to Ledderhose disease to be even known as DD of the foot
      • incidence of Ledderhose disease is nearly 15% in patients with Dupuytren's (2)

Reference:

  • de Bree E, Zoetmulder FA, Keus RB, Peterse HL, van Coevorden F. Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg. 2004;187:33-8.
  • Trybus M, Bednarek M, Budzynski P, Gniadek M, Lorkowski J. Concomitance of ledderhose's disease with dupuytren's contracture. Own experience. PrzeglLek. 2012;69:663-6



Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.